Overview:
With a line of sight to over 50% of all industry-sponsored trials globally at any given point in time, including 175,000 unique investigators, the Xcellerate Site List Tool can identify the most productive investigators and countries for any indication or therapeutic area of interest based on the speed and volume of historical enrollment, relative start-up speed, and the quality of recruitment for a site.
We can also determine the optimal country-site mix for selection using the same data, as this information is aggregated at the country and study level. This informs decisions that can optimize patient enrollment, avoids costs associated with poor and non-performing sites and cuts down on the unnecessary inclusion of additional countries.
The Xcellerate Site List Tool has contributed to streamlining patient recruitment by reducing the number of non-performing sites.